PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines

McCubrey, James A.2022-02-042022-02-042017-02-201949-2553http://hdl.handle.net/10342/9623en-USPI3K isoform inhibitionCT B-acute lymphoblastic leukemia (B-ALL)B-cell progenitorPI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell LinesArticle10.18632/oncotarget.15542